Stock Ratings | Lake Street lowered its price target for OS Therapies (OSTX) to $13, indicating a potential upside of 638.64%; Citi raised its price target for Micron Technology (MU) to $840
Strategy MSTR | 0.00 | |
Cipher Mining CIFR | 0.00 | |
Relay Therapeutics, Inc. RLAY | 0.00 | |
NeOnc Technologies Holdings, Inc. NTHI | 0.00 | |
OS Therapies Incorporated OSTX | 0.00 |
The ratings of major US investment banks are used to track the latest valuations and target prices on Wall Street daily, and to explore potential equity investment opportunities.
Risk warning:
Investing in small-cap stocks can be risky. Be prepared for potential challenges related to liquidity, high volatility, limited information, and financial instability. Always diversify your investments.
Today's key assessments and concerns
TD Cowen: Maintaining Strategy ( Strategy(MSTR.US) ) rating at "Buy", while raising the price target from $395 to $400.
Morgan Stanley: Maintaining Cipher Digital's ( Cipher Mining(CIFR.US) ) rating at "Overweight", while raising the price target from $40.5 to $42.5.
Raymond James: Maintaining Relay Therapeutics ( Relay Therapeutics, Inc.(RLAY.US) ) rating at "Strong Buy", while raising the price target from $23 to $26.
Alliance Global Partners: Initial rating for NeOnc Technologies Holdings, Inc.(NTHI.US) ) stock at "buy", with a target price of $13.
Lake Street: Maintaining a "buy" rating on OS Therapies ( OS Therapies Incorporated(OSTX.US) ), while lowering the price target from $14 to $13.
| The symbol | Classification | Target price | Current price | Percentage of potential increase/decrease | (Classification) Agency |
| Strategy(MSTR.US) | to lift | $400.0 | $164.63 | 142.97% | TD Cowen |
| Cipher Mining(CIFR.US) | to lift | $42.5 | $18.8 | 126.06% | Morgan Stanley |
| Relay Therapeutics, Inc.(RLAY.US) | to lift | $26.0 | $12.07 | 115.41% | Raymond James |
| TeraWulf Inc.(WULF.US) | to lift | $42.0 | $21.34 | 96.81% | Morgan Stanley |
| Alumis Inc.(ALMS.US) | to lift | $40.0 | $21,525 | 85.83% | Chardan Capital |
| NeOnc Technologies Holdings, Inc.(NTHI.US) | Initial classification | $13.0 | $5.48 | 137.23% | Alliance Global Partners |
| OS Therapies Incorporated(OSTX.US) | cut | $13.0 | $1.76 | 638.64% | Lake Street |
| Biofrontera Inc.(BFRI.US) | cut | $3.0 | $0.806 | 272.21% | Benchmark |
| GH Research Plc(GHRS.US) | cut | $65.0 | $21.94 | 196.26% | HC Wainwright & Co. |
| Orchestra BioMed Holdings, Inc.(OBIO.US) | cut | $10.0 | $4.0 | 150.0% | B. Riley Securities |
comments:
Target price unit and current price: US Dollar;
Current price: As of the latest closing price of US stocks;
Potential percentage increase/potential decrease = (Agency target price - current price) / current price 100% (Current price = Last closing price up to the time of the count)
Lifting
Evercore ISI Group: Maintaining Advanced Micro Devices Advanced Micro Devices, Inc.(AMD.US) rating at "Outperform Market", while raising the price target from $358 to $579.
Morgan Stanley: Maintaining Circle Internet Group's ( Circle(CRCL.US) ) rating at "Market-equal weight," while raising the price target from $80 to $106.
Truist Securities: Maintaining a "Buy" rating on CrowdStrike Holdings CrowdStrike(CRWD.US) ), with a price target raised from $550 to $650.
Evercore ISI Group: Maintaining Marvell Technology's ( Marvell Technology, Inc.(MRVL.US) ) rating at "Outperform Market", while raising the price target from $133 to $155.
TD Cowen: Maintaining Strategy ( Strategy(MSTR.US) ) rating at "Buy", while raising the price target from $395 to $400.
Citigroup: Maintaining a "buy" rating on Micron Technology Micron Technology, Inc.(MU.US) , while raising its price target from $425 to $840.
Mizuho: Maintaining Micron Technology's Micron Technology, Inc.(MU.US) ) rating at "Outperform Market", while raising the price target from $740 to $800.
HSBC: Maintaining a "buy" rating on NVIDIA NVIDIA Corporation(NVDA.US) ) stock, while raising the price target from $295 to $325.
First Coverage
Citigroup: BioMarin BioMarin Pharmaceutical Inc.(BMRN.US) ) stock has a preliminary "buy" rating, with a target price of $75.
Loop Capital: Initial rating for Corpay ( Corpay, Inc.(CPAY.US) ) stock at "buy", with a target price of $406.
Citigroup: Initial rating for Cytokinetics ( Cytokinetics, Incorporated(CYTK.US) ) stock at "buy", with a target price of $99.
Guggenheim: Preliminary rating for X-Energy ( X-Energy, Inc. Class A(XE.US) ) stock at "Buy", with a target price of $57.
reduction
B of A Securities: Maintaining a "neutral" rating on Hims & Hers Health ( Hims & Hers Health(HIMS.US) ), while lowering the price target from $30 to $28.
Rosenblatt: Maintaining a "buy" rating on Sirius XM Holdings ( Sirius XM Holdings Inc.(SIRI.US) ), while lowering the price target from $46 to $45.
BMO Capital: Downgraded its rating on Hanover Insurance ( Hanover Insurance Group, Inc.(THG.US) ) to "Market Match," while raising its price target from $194 to $203.
B of A Securities: Maintaining a "neutral" rating on Thomson Reuters ( Thomson Reuters Corporation(TRI.US) ) stock, while lowering the price target from $115 to $98.
Editor's Note: This content was created by Saham's AI-powered SaaS tool and reviewed by our editorial team.
Risk Warning: Investing involves risk. Securities may rise, fall, or become worthless. Investing does not guarantee profits and may result in losses. Past performance is not necessarily indicative of future results. Before making any investment decision, investors should assess their financial situation, investment objectives, experience, risk tolerance, and understand the nature of the investment products and their associated risks. For more details on the nature and risks of each investment product, please read the relevant offering documents carefully. If you have any questions, it is advisable to seek independent professional advice.